LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Inicio・Lista de Acciones・NeoGenomics Inc

NeoGenomics Inc

Cerrado

9.23 1.54

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

9.19

Máximo

9.25

Métricas clave
By Trading Economics
Ingresos	-7.2M -17M
Ventas	-3.5M 187M
BPA	0.01
Margen de beneficios	-9.164
Empleados	2,500
EBITDA	-5.8M -567K

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+61.76% upside

Dividendos
By Dow Jones
Próximas Ganancias	28 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-31M 1.1B
Apertura anterior	7.69
Cierre anterior	9.23

NeoGenomics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 may 2026, 18:09 UTC

Charlas de Mercado

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 may 2026, 16:54 UTC

Charlas de Mercado

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 may 2026, 14:53 UTC

Charlas de Mercado

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22 may 2026, 11:51 UTC

Charlas de Mercado

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22 may 2026, 07:28 UTC

Charlas de Mercado

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

21 may 2026, 17:04 UTC

Charlas de Mercado

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

21 may 2026, 16:08 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

21 may 2026, 16:08 UTC

Charlas de Mercado

Zcash Backtracks After Yesterday's Surge -- Market Talk

21 may 2026, 15:39 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

21 may 2026, 15:39 UTC

Charlas de Mercado

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

21 may 2026, 13:52 UTC

Charlas de Mercado

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

21 may 2026, 07:03 UTC

Charlas de Mercado

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

20 may 2026, 17:08 UTC

Charlas de Mercado

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20 may 2026, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

20 may 2026, 15:51 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 may 2026, 15:51 UTC

Charlas de Mercado

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20 may 2026, 15:39 UTC

Charlas de Mercado

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20 may 2026, 13:08 UTC

Charlas de Mercado

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20 may 2026, 12:44 UTC

Charlas de Mercado

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20 may 2026, 07:25 UTC

Charlas de Mercado

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

19 may 2026, 15:54 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 may 2026, 15:54 UTC

Charlas de Mercado

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19 may 2026, 14:51 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 may 2026, 14:51 UTC

Charlas de Mercado

Ethereum Down From Near-Term High -- Market Talk

19 may 2026, 08:26 UTC

Charlas de Mercado

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19 may 2026, 08:26 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

18 may 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

18 may 2026, 17:22 UTC

Charlas de Mercado

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Comparación entre iguales

Cambio de precio

NeoGenomics Inc previsión

Precio Objetivo

By TipRanks

61.76% repunte

Estimación a 12 Meses

Media 14.93 USD 61.76%

Máximo 25 USD

Mínimo 11 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para NeoGenomics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

Comprar

Mantener

Vender

De acuerdo con 10 analistas que ofrecen calificaciones bursátiles a para NeoGenomics Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.